SKI Market

A+| A| A-|

Indian Indices

Sensex

74,563.92 -1,470.50
( -1.93%)

Global Indices

Nasdaq

46,583.62 -115.24
(-0.25%)

Dow Jones

6,653.27 -40.35
(-0.60%)

Hang Seng

53,838.16 -614.80
(-1.13%)

Nikkei 225

10,249.42 -55.73
(-0.54%)

Forex

USD-INR

92.29 0.37
(0.40%)

EUR-INR

106.44 -0.15
(-0.14%)

GBP-INR

123.36 -0.03
(-0.03%)

JPY-INR

0.58 0.00
(0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533573

INE901L01018

267.3488556

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APLLTD

26.3

13348.6

EPS(TTM)

Face Value()

Div & Yield %

25.82

1.62

Back

emco ltd

Terai Tea Co reports standalone net loss of Rs 3.43 crore in the September 2025 quarter

Nov 16,2025

Net loss of Terai Tea Co reported to Rs 3.43 crore in the quarter ended September 2025 as against net profit of Rs 8.52 crore during the previous quarter ended September 2024. Sales declined 51.12% to Rs 15.32 crore in the quarter ended September 2025 as against Rs 31.34 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	15.32	31.34	-51
OPM %	-15.54	4.53	-
PBDT	-3.09	8.90	PL
PBT	-3.43	8.52	PL
NP	-3.43	8.52	PL

74,563.92 -1,470.50 ( -1.93%)

46,583.62 -115.24 (-0.25%)

6,653.27 -40.35 (-0.60%)

53,838.16 -614.80 (-1.13%)

10,249.42 -55.73 (-0.54%)

92.29 0.37 (0.40%)

106.44 -0.15 (-0.14%)

123.36 -0.03 (-0.03%)

0.58 0.00 (0.05%)